Drug intelligence / Profile preview

Memoril Mite

Development stage
Unknown
Lead developer
Meditop Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Memoril Mite is a 600 mg film-coated tablet containing piracetam, a nootropic agent developed and manufactured by Meditop Pharmaceutical. It is indicated for the improvement of memory, attention, and motivation in adults, particularly those experiencing age-related cognitive decline or memory disorders. As a derivative of gamma-aminobutyric acid (GABA), piracetam's mechanism of action involves the positive allosteric modulation of AMPA-type glutamate receptors and the restoration of neuronal membrane fluidity, which enhances neuroplasticity and neurotransmission. Additionally, it improves cerebral microcirculation by reducing blood viscosity and inhibiting platelet aggregation. In the Hungarian market, Memoril Mite is recognized as a non-prescription (OTC) medication for cognitive complaints.

Brand names
Memoril Mite
Other names
piracetam
02

Targets

AMPAR (AMPA receptor)

Beyond the preview

Go deeper on Memoril Mite.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Memoril Mite.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call